Therapeutic Potential of 5-HT6 Receptor Agonists.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2015-07-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1021/acs.jmedchem.5b00179PMID 26099069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SNX14 is a bifunctional negative regulator for neuronal 5‐HT6 receptor signaling

  2015cited by this paper
• Pharmacological Evidence for 5-HT6 Receptor Modulation of 5-HT Neuron Firing in Vivo.

  2015cited by this paper
• The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia

  2014cited by this paper
• Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.

  2014cited by this paper
• Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth.

  2014cited by this paper
• Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer's disease.

  2014cited by this paper
• Computational approaches to the design of novel 5-HT6 R ligands

  2014cited by this paper
• 5-HT6 receptors and Alzheimer's disease

  2013cited by this paper
• The effects of systemic and local microinjection into the central nervous system of the selective serotonin 5-HT6 receptor agonist WAY-208466 on sleep and wakefulness in the rat.

  2013cited by this paper
• Evidence for a role of a dopamine/5-HT6 receptor interaction in cocaine reinforcement.

  2013cited by this paper
• Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.

  2013cited by this paper
• Structural Features for Functional Selectivity at Serotonin Receptors

  2013cited by this paper
• The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats

  2013cited by this paper
• Secondary mechanical allodynia and hyperalgesia depend on descending facilitation mediated by spinal 5-HT₄, 5-HT₆ and 5-HT₇ receptors.

  2012cited by this paper
• Selective serotonin receptor stimulation of the medial nucleus accumbens differentially affects appetitive motivation for food on a progressive ratio schedule of reinforcement.

  2012cited by this paper
• Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

  2012cited by this paper
• 5-HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia

  2012cited by this paper
• Serotonergic Drugs

  2012cited by this paper
• 5‐HT6 receptor agonists and antagonists enhance learning and memory in a conditioned emotion response paradigm by modulation of cholinergic and glutamatergic mechanisms

  2012cited by this paper
• Investigation of the Structure Requirement for 5-HT6 Binding Affinity of Arylsulfonyl Derivatives: A Computational Study

  2011cited by this paper
• ST1936 stimulates cAMP, Ca2+, ERK1/2 and Fyn kinase through a full activation of cloned human 5-HT6 receptors.

  2011cited by this paper
• 5-HT(6) receptor and cognition.

  2011cited by this paper
• Role of peripheral 5‐HT4, 5‐HT6, and 5‐HT7 receptors in development and maintenance of secondary mechanical allodynia and hyperalgesia

  2011cited by this paper
• E-6801, a 5-HT6 receptor agonist, improves recognition memory by combined modulation of cholinergic and glutamatergic neurotransmission in the rat

  2011cited by this paper
• The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration

  2011cited by this paper
• Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission.

  2011cited by this paper
• Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats

  2011cited by this paper
• Benzimidazole derivatives as new serotonin 5-HT6 receptor antagonists. Molecular mechanisms of receptor inactivation.

  2010cited by this paper
• Effects of serotonin (5-HT)_6 receptor ligands on responding for cocaine reward and seeking in rats

  2010cited by this paper
• 5-HT6 medicinal chemistry.

  2010cited by this paper
• Activation of 5-HT6 receptors facilitates attentional set shifting

  2009cited by this paper
• Role of peripheral and spinal 5-HT6 receptors according to the rat formalin test.

  2009cited by this paper
• Indene-based scaffolds. 2. An indole-indene switch: discovery of novel indenylsulfonamides as 5-HT6 serotonin receptor agonists.

  2009cited by this paper
• Identification of novel indanylsulfonamide guanylhydrazones as potent 5-HT6 serotonin receptor antagonists.

  2009cited by this paper
• Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies.

  2008cited by this paper
• The effects of the 5-HT(6) receptor agonist EMD and the 5-HT(7) receptor agonist AS19 on memory formation.

  2008cited by this paper
• Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.

  2008cited by this paper
• Neuropharmacological Profile of Novel and Selective 5-HT6 Receptor Agonists: WAY-181187 and WAY-208466

  2008cited by this paper
• An update on the role of the 5-hydroxytryptamine6 receptor in cognitive function.

  2008cited by this paper
• The effects of pharmacological blockade of the 5-HT(6) receptor on formalin-evoked nociceptive behaviour, locomotor activity and hypothalamo-pituitary-adrenal axis activity in rats.

  2007cited by this paper
• Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

  2007cited by this paper
• Biochemical and Behavioral Evidence for Antidepressant-Like Effects of 5-HT6 Receptor Stimulation

  2007cited by this paper
• The Novel Cellular Mechanism of Human 5-HT6 Receptor through an Interaction with Fyn*

  2007cited by this paper
• Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist.

  2007cited by this paper
• Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity.

  2007cited by this paper
• Endogenous Serotonin Excites Striatal Cholinergic Interneurons via the Activation of 5-HT 2C, 5-HT6, and 5-HT7 Serotonin Receptors: Implications for Extrapyramidal Side Effects of Serotonin Reuptake Inhibitors

  2007cited by this paper
• Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex

  2007cited by this paper
• Chronic 5‐HT6 receptor modulation by E‐6837 induces hypophagia and sustained weight loss in diet‐induced obese rats

  2006cited by this paper
• Expression of mRNA for multiple serotonin (5-HT) receptor types/subtypes by the peripheral blood mononuclear cells of rhesus macaques.

  2006cited by this paper
• 2-Alkyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as novel 5-HT6 receptor agonists.

  2005cited by this paper
• Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists.

  2005cited by this paper
• Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists.

  2005cited by this paper
• Medicinal chemistry driven approaches toward novel and selective serotonin 5-HT6 receptor ligands.

  2005cited by this paper
• N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists.

  2005cited by this paper
• 5-ht6 receptors.

  2004cited by this paper
• Possible differences in modes of agonist and antagonist binding at human 5-HT6 receptors.

  2004cited by this paper
• 1-(2-Aminoethyl)-3-(arylsulfonyl)-1H-indoles as novel 5-HT6 receptor ligands.

  2004cited by this paper
• Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).

  2003cited by this paper
• Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.

  2003cited by this paper
• Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist.

  2003cited by this paper
• Characterization of the 5-HT6 receptor coupled to Ca2+ signaling using an enabling chimeric G-protein.

  2003cited by this paper
• The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585.

  2002cited by this paper
• A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze.

  2001cited by this paper
• N-Arylsulfonylindole derivatives as serotonin 5-HT(6) receptor ligands.

  2001cited by this paper
• The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus.

  2001cited by this paper
• The 5-HT6 Receptor Antagonist SB-271046 Selectively Enhances Excitatory Neurotransmission in the Rat Frontal Cortex and Hippocampus

  2001cited by this paper
• In vivo effects of the 5‐HT6 antagonist SB‐271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5‐HT, glutamate and aspartate

  2000cited by this paper
• 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.

  2000cited by this paper
• mRNA expression of serotonin receptors in cells of the immune tissues of the rat.

  2000cited by this paper
• N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists.

  2000cited by this paper
• Antibodies and Antisense Oligonucleotide for Probing the Distribution and Putative Functions of Central 5-HT6Receptors

  1999cited by this paper
• Characterization of Ro 04‐6790 and Ro 63‐0563: potent and selective antagonists at human and rat 5‐HT6 receptors

  1998cited by this paper
• Characterization of 5-ht6 receptor and expression of 5-ht6 mRNA in the rat brain during ontogenetic development

  1998cited by this paper
• Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system.

  1997cited by this paper
• Cloning, Characterization, and Chromosomal Localization of a Human 5‐HT6 Serotonin Receptor

  1996cited by this paper
• Quantitative RT‐PCR distribution of serotonin 5‐HT6 receptor mRNA in the central nervous system of control or 5,7‐dihydroxytryptamine‐treated rats

  1996cited by this paper
• Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry.

  1995cited by this paper
• 5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture.

  1994cited by this paper
• Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.

  1994cited by this paper
• Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.

  1993cited by this paper
• A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation.

  1993cited by this paper

• Interfacial Asymmetrically Coordinated Zn-MOF for High-Efficiency Electrosynthetic Oxime.

  2025cites this paper
• Pharmacophoric Determinants of 5-HT₂A Agonism: A Machine Learning–Based QSAR Study of Tryptamine Derivatives Using Random Forest for CNS Drug Design

  2025cites this paper
• Repeated 5-HT6 receptor activation facilitates flexible behavior in C57BL/6J mice.

  2025cites this paper
• Histone deacetylase 6 inhibitors in Alzheimer's disease therapy: structure design and challenges.

  2025cites this paper
• p-Synephrine: an overview of physicochemical properties, toxicity, biological and pharmacological activity

  2025cites this paper
• Therapeutical Potential of 5-HT6 of Receptor Modulation in Neurological and Psychiatric Conditions

  2024cites this paper
• New Chemo-, Regio- and Stereoselective Reactions and Methods in Organic Synthesis

  2024cites this paper
• Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders

  2024cites this paper
• Diverse role, structural trends, and applications of fluorinated sulphonamide compounds in agrochemical and pharmaceutical fields

  2024cites this paper
• The Clinical Potential of Dimethyltryptamine: Breakthroughs into the Other Side of Mental Illness, Neurodegeneration, and Consciousness

  2024cites this paper
• Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders

  2023cites this paper
• Synthesis, computational and experimental pharmacological studies for (thio)ether-triazine 5-HT6R ligands with noticeable action on AChE/BChE and chalcogen-dependent intrinsic activity in search for new class of drugs against Alzheimer's disease.

  2023cites this paper
• Impact of 5-HT6 Receptor Subcellular Localization on Its Signaling and Its Pathophysiological Roles

  2023cites this paper
• Serotonin receptors in epilepsy: Novel treatment targets?

  2022cites this paper
• The Synthesis and Absolute Configuration of Enantiomeric Pure (R)- and (S)-3-(piperidin-3-yl)-1H-Indole Derivatives

  2022cites this paper
• Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders

  2022cites this paper
• Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer’s Disease: Can It Work from a Molecular Point of View?

  2022cites this paper
• Perceiving the Concealed and Unreported Pharmacophoric Features of the 5-Hydroxytryptamine Receptor Using Balanced QSAR Analysis

  2022cites this paper
• A 5-HT6R Agonist Alleviates Cognitive Dysfunction after Traumatic Brain Injury in Rats by Increasing BDNF Expression.

  2022cites this paper
• Serotonin Receptors as Therapeutic Targets for Autism Spectrum Disorder Treatment

  2022cites this paper
• Radiotracers for the Central Serotoninergic System

  2022cites this paper
• N-(2,7-dimethyl-2-alkyl-2H-chromen-6-yl)sulfonamide derivatives as selective serotonin 5-HT6 receptor antagonists: Design, synthesis, and biological evaluation

  2022cites this paper
• Drug design of new 5-HT6R antagonists aided by artificial neural networks.

  2021cites this paper
• The Phenoxyalkyltriazine Antagonists for 5-HT6 Receptor with Promising Procognitive and Pharmacokinetic Properties In Vivo in Search for a Novel Therapeutic Approach to Dementia Diseases

  2021cites this paper
• Novel N-Arylsulfonylindoles Targeted as Ligands of the 5-HT6 Receptor. Insights on the Influence of C-5 Substitution on Ligand Affinity

  2021cites this paper
• Development of Novel Potential Pleiotropic Compounds of Interest in Alzheimer’s Disease Treatment through Rigidification Strategy

  2021cites this paper
• Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States.

  2021cites this paper
• University of Birmingham Central 5-HT receptors and their function ; present and future

  2020cites this paper
• The 5-HT6 receptor interactome: new insight in receptor signaling and its impact on brain physiology and pathologies.

  2020cites this paper
• Translational Potential of Rats in Research

  2020cites this paper
• Dietary restriction of amino acids for Cancer therapy

  2020cites this paper
• Preclinical validation of [18F]2FNQ1P as a specific PET radiotracer of 5-HT6 receptors in rat, pig, non-human primate and human brain tissue.

  2020cites this paper
• Effects of Exercise Training on Anxious–Depressive-like Behavior in Alzheimer Rat

  2020cites this paper
• Drug design of new 5-HT6 antagonists: a QSAR study of arylsulfonamide derivatives

  2020cites this paper
• Synthesis, pharmacological evaluations and molecular docking studies on a new 1,3,4,11b-tetrahydro-1H-fluoreno[9,1-cd]azepine framework: rigidification of D1 receptor selective 1-phenylbenzazepines and discovery of a new 5-HT6 receptor scaffold.

  2020cites this paper
• The Antagonism of 5-HT6 Receptor Attenuates Current-Induced Spikes and Improves Long-Term Potentiation via the Regulation of M-Currents in a Pilocarpine-Induced Epilepsy Model

  2020cites this paper
• Cp*Co(III) Catalyzed Ketone Directed Ortho C-H Activation for Synthesis of Indene Derivatives.

  2020cites this paper
• Central 5-HT receptors and their function; present and future.

  2020cites this paper
• Evaluation of serotonin receptors (5HTR2A and 5HTR3A) mRNA expression changes in tumor of breast cancer patients

  2020cites this paper
• Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact

  2020cites this paper
• Pleiotropic prodrugs: Design of a dual butyrylcholinesterase inhibitor and 5-HT6 receptor antagonist with therapeutic interest in Alzheimer's disease.

  2020cites this paper
• Constitutive Activity of Serotonin Receptor 6 Regulates Human Cerebral Organoids Formation and Depression-like Behaviors

  2020cites this paper
• Drug Targets

  2020cites this paper
• The pronociceptive role of 5-HT6 receptors in ventrolateral orbital cortex in a rat formalin test model.

  2019cites this paper
• A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotonergic Subtype 6 Receptor (5-HT6R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer’s Disease

  2019cites this paper
• Tandem Addition/Electrocyclization/Benzylation of Alkyl Aryl-1,3-dienes and Aromatic Aldehydes: Access to Highly Substituted Indenes.

  2019cites this paper
• Access to Substituted Indenol Ethers via a Regioselective Intermolecular Carbopalladation Cascade.

  2019cites this paper
• Serotonin receptor imaging by 18F-PET

  2019cites this paper
• Change in Expression of 5-HT6 Receptor at Different Stages of Alzheimer’s Disease: A Postmortem Study with the PET Radiopharmaceutical [18F]2FNQ1P

  2019cites this paper
• Toxicological Aspects and Determination of the Main Components of Ayahuasca: A Critical Review

  2019cites this paper
• The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment

  2019cites this paper
• Recent Advances in the Synthesis of Indenes

  2019cites this paper
• Are the Hydantoin-1,3,5-triazine 5-HT6R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo Assays and ADME-Tox Profile In Vitro

  2019influential citation
• Reaction of N,N-Dimethyltryptamine with Dichloromethane Under Common Experimental Conditions

  2018cites this paper
• Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT6 Receptor Antagonist SB-399885

  2018cites this paper
• 5-Hydroxytryptamine Receptor 6

  2018cites this paper
• 5‐HT6 receptor agonist and memory‐enhancing properties of hypidone hydrochloride (YL‐0919), a novel 5‐HT1A receptor partial agonist and SSRI

  2018cites this paper
• Dark Classics in Chemical Neuroscience: N, N-Dimethyltryptamine (DMT).

  2018cites this paper
• The role of 5 HT6-receptor antagonists in Alzheimer’s disease: an update

  2018cites this paper
• Gold(I)/Xiang-Phos-Catalyzed Asymmetric Intramolecular Cyclopropanation of Indenes and Trisubstituted Alkenes.

  2018cites this paper
• The computer-aided discovery of novel family of the 5-HT6 serotonin receptor ligands among derivatives of 4-benzyl-1,3,5-triazine.

  2017cites this paper
• AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation

  2017cites this paper
• Design, Synthesis and Biological Evaluation of Potent Antioxidant 1-(2,5-Dimethoxybenzyl)-4-arylpiperazines and N-Azolyl Substituted 2-(4-Arylpiperazin-1-yl)

  2017cites this paper
• Receptors and Second Messengers in the Basal Ganglia

  2017cites this paper
• Serotonin and brain function: a tale of two receptors

  2017cites this paper
• Compound Ranking Based on Fuzzy Three-Dimensional Similarity Improves the Performance of Docking into Homology Models of G-Protein-Coupled Receptors

  2017cites this paper
• Enantioselective N-Heterocyclic Carbene Catalyzed Synthesis of Functionalized Indenes.

  2017cites this paper
• Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications

  2017cites this paper
• Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment.

  2017cites this paper
• Metabolic and Cardiovascular Benefits and Risks of EMD386088—A 5-HT6 Receptor Partial Agonist and Dopamine Transporter Inhibitor

  2017cites this paper
• Rodent models in neuroscience research: is it a rat race?

  2016cites this paper
• Sulfonamide Derivatives and Pharmaceutical Applications Thereof.

  2016cites this paper
• Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia.

  2016cites this paper
• Further Advances in Optimizing (2-Phenylcyclopropyl)methylamines as Novel Serotonin 2C Agonists: Effects on Hyperlocomotion, Prepulse Inhibition, and Cognition Models.

  2016cites this paper
• Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer's Disease.

  2016cites this paper
• Distribution of serotonin receptor 5-HT6 mRNA in rat neuronal subpopulations: A double in situ hybridization study.

  2015cites this paper
• Pharmacophoric Determinants of 5-HT2A Agonism: A Machine Learning–Based QSAR Study of Tryptamine Derivatives Using Random Forest for CNS Drug Design

  year unknowncites this paper
• Short communication Post acquisition 5-HT6 receptor agonist EMD386088 administration impairs consolidation of a spatial discrimination in mice

  year unknowninfluential citation